Preparation and evaluation of methyl salicylate counter- Irritant emulgel of mefenamic acid
Journal Title: International Journal of Pharmaceutical and Medicinal Reserach - Year 2013, Vol 1, Issue 1
Abstract
Topical delivery of hydrophobic drug with good patient acceptance is a big challenge which is successfully handled by Emulgels. The objective of the study was to prepare emulgel of mefenamic acid, a NSAID, using Carbopol 934P as a gelling agent and methyl salicylates as counter irritant agent. Theemulsion was prepared and it was incorporated in gel base in the ratio of 1:1. The prepared six formulations were evaluated for rheological studies, spreading coefficient studies, bioadhesion strength, in vitro release and ex vivo release studies. From the obtained results it can be concluded that topical emulgel of Mefenamic acid possess great suitability for topical delivery.
Authors and Affiliations
Vivek P. Chavda, Jitendra Patel, Kaushik Parmar, Sanjay Nakum, Moinuddin M. Soniwala, Jayant R. Chavda
Keywords
Related Articles
- EP ID EP31448
- DOI -
- Views 521
- Downloads 3
Ancient view of cataract in relevance to modern science
Cataracts are the leading cause of curable blindness, till date there is no medicine claimed to have the capacity to dissolve the cataractous lens. The researches either to delay the onset or to prevent the progress of...
Polymeric systems as controlled release drug products: A review
The use of various new techniques and therapeutic systems to obtain a controlled drug release in microbial infections is a more and more exploited approach in the modern pharmaceutical technology. Growing interest in thi...
Anti-Diabetic potential of Girardinia heterophylla in alloxan induced rat model
Diabetes mellitus is the most common and significant chronic endocrine disorder affecting approximately 200 million individuals worldwide. The current availability of allopathic medicines is not giving optimum response...
Synthesis Design of an Anti-Obesity Agent ‘Sibutramine’: A Reatrosynthetic Approach
Organic synthesis plays the central role in the process of drug design and development. Retrosynthetic analysis represents a very powerful tool for designing convergent and economical synthetic routes of targeted drugs...
Incretins: based therapy for type-2 Diabetes mellitus (T2DM)
The treatment of type 2 diabetes mellitus is metformin and sulfonylurea (SU) as first-line anti- diabetic therapies for many years. It is the first line treatment though the combination results in a progressive declin...